168 related articles for article (PubMed ID: 23422915)
1. Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms.
Ramage G; Jose A; Sherry L; Lappin DF; Jones B; Williams C
Antimicrob Agents Chemother; 2013 May; 57(5):2369-71. PubMed ID: 23422915
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.
Ko KS; Lee JY; Song JH; Peck KR
J Korean Med Sci; 2010 Dec; 25(12):1722-6. PubMed ID: 21165285
[TBL] [Abstract][Full Text] [Related]
3. Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.
Simitsopoulou M; Kyrpitzi D; Velegraki A; Walsh TJ; Roilides E
Antimicrob Agents Chemother; 2014 Aug; 58(8):4953-6. PubMed ID: 24890585
[TBL] [Abstract][Full Text] [Related]
4. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases.
Tobudic S; Lassnigg A; Kratzer C; Graninger W; Presterl E
Mycoses; 2010 May; 53(3):208-14. PubMed ID: 19298353
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of antifungal combinations against Candida albicans biofilms.
Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
[TBL] [Abstract][Full Text] [Related]
6. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
Shinde RB; Chauhan NM; Raut JS; Karuppayil SM
Ann Clin Microbiol Antimicrob; 2012 Oct; 11():27. PubMed ID: 23035934
[TBL] [Abstract][Full Text] [Related]
7. Quinacrine inhibits Candida albicans growth and filamentation at neutral pH.
Kulkarny VV; Chavez-Dozal A; Rane HS; Jahng M; Bernardo SM; Parra KJ; Lee SA
Antimicrob Agents Chemother; 2014 Dec; 58(12):7501-9. PubMed ID: 25288082
[TBL] [Abstract][Full Text] [Related]
8. Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B.
Sandovsky-Losica H; Shwartzman R; Lahat Y; Segal E
J Antimicrob Chemother; 2008 Sep; 62(3):635-7. PubMed ID: 18490373
[No Abstract] [Full Text] [Related]
9. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates.
Shuford JA; Piper KE; Steckelberg JM; Patel R
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):277-81. PubMed ID: 17141454
[TBL] [Abstract][Full Text] [Related]
10. Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion.
Uppuluri P; Srinivasan A; Ramasubramanian A; Lopez-Ribot JL
Antimicrob Agents Chemother; 2011 Jul; 55(7):3591-3. PubMed ID: 21518839
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the echinocandin caspofungin with amphotericin B or voriconazole against Aspergillus biofilms in vitro.
Liu W; Li L; Sun Y; Chen W; Wan Z; Li R; Liu W
Antimicrob Agents Chemother; 2012 Dec; 56(12):6414-6. PubMed ID: 23027186
[TBL] [Abstract][Full Text] [Related]
12. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.
Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K
J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780
[TBL] [Abstract][Full Text] [Related]
13. Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products.
Soler L; Rodriguez JC; Belda S; Cremades R; Ruiz-Garcia M; Lopez P; Royo G
J Chemother; 2010 Aug; 22(4):283-4. PubMed ID: 20685636
[No Abstract] [Full Text] [Related]
14. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model.
Shuford JA; Rouse MS; Piper KE; Steckelberg JM; Patel R
J Infect Dis; 2006 Sep; 194(5):710-3. PubMed ID: 16897672
[TBL] [Abstract][Full Text] [Related]
15. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.
Mowat E; Lang S; Williams C; McCulloch E; Jones B; Ramage G
J Antimicrob Chemother; 2008 Dec; 62(6):1281-4. PubMed ID: 18819968
[TBL] [Abstract][Full Text] [Related]
16. Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles.
Shinde RB; Raut JS; Chauhan NM; Karuppayil SM
Braz J Infect Dis; 2013; 17(4):395-400. PubMed ID: 23602464
[TBL] [Abstract][Full Text] [Related]
17. Liposomal amphotericin B eradicates Candida albicans biofilm in a continuous catheter flow model.
Seidler M; Salvenmoser S; Müller FM
FEMS Yeast Res; 2010 Jun; 10(4):492-5. PubMed ID: 20345899
[TBL] [Abstract][Full Text] [Related]
18. A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms.
DiDone L; Oga D; Krysan DJ
Yeast; 2011 Aug; 28(8):561-8. PubMed ID: 21674619
[TBL] [Abstract][Full Text] [Related]
19. Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.
Chatzimoschou A; Katragkou A; Simitsopoulou M; Antachopoulos C; Georgiadou E; Walsh TJ; Roilides E
Antimicrob Agents Chemother; 2011 May; 55(5):1968-74. PubMed ID: 21343465
[TBL] [Abstract][Full Text] [Related]
20. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
El-Azizi M; Farag N; Khardori N
Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]